This Government Contract opportunity from Department Of Defense was posted on May 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Pharmaceutical Manufacturing of Carprofen Tablets
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the manufacturing of chewable carprofen tablets, each containing 100mg of the active ingredient, designed specifically for veterinary use. These tablets must comply with FDA regulations and are to be packaged in bottles containing 60 tablets each. The production will serve as a subcontract opportunity under the Department of Defense, facilitated through the Medical Supply Chain Pharm FSA agency. The work is to be performed at Fort Bragg, with a solicitation posted on May 20, 2026, and a response deadline set for May 26, 2026. The contract falls under the North American Industry Classification System (NAICS) code 325412, which relates to pharmaceutical manufacturing. The project emphasizes strict adherence to pharmaceutical standards and regulatory compliance for veterinary medicinal products within a precise timeline for proposal submissions.
General Info
Agency
NAICS
Place of Performance
FORT BRAGG, NC, 28310, USSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
